Macrocyclic peptides active against the hepatitis C virus
US7749961B2 · kind B2 · utility
1Cited by
23References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2005 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Sep 16, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I):wherein R1, R2, X, R3, D, and the dotted line b are as defined herein; or a pharmaceutically acceptable salt or ester thereof, are useful as inhibitors of the HCV NS3 protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.